There's some people around here who need to know that "other" robotics companies may have an arguably better product, but, these "other" companies are horribly pathetic at business / execution / planning, or lack focus, and because of these issues, their arguably superior robots will remain obscure, failed novelties.
the best product maker is not always the big market winner. Example look at ISR^, wow- They have milked an old junkbot for 20+ years, making billions in revenue, simply because they were the best at business execution and the only FDA approved market player.
Now we have Senhance firmly in the market as a player with multiple approvals. Let's say it is not the best bot, for arguments sake, but is more than adequate for approved indications / procedures. Guess what- TRXC will still make tons of cash because the company is excellent at planning and execution, and hospitals need/want affordable bots.
And - no FDA approved competitors any time soon. Only 2 FDA approved players in this space, do the math.
Business folks. bank on it.
News 
Market Data 
Discover 
